Biotech · Public company · Cambridge, MA, US
Prime Medicine, Inc.
Ticker PRME · SEC CIK 0001894562
Track this companyFree. Adds Prime Medicine, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- PM359Phase 2 · Chronic Granulomatous DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PM577aPhase 2 · Wilson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)PHASE1_PHASE2 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07748403 · fetched Nov 12, 2026
- Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical TrialACTIVE_NOT_RECRUITING · started Dec 29, 2025ClinicalTrials.gov NCT07226622 · fetched Nov 12, 2026
- A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )PHASE1_PHASE2 · ENROLLING_BY_INVITATION · started Oct 17, 2024ClinicalTrials.gov NCT06559176 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 8, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 16, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 7, 2025 · fetched Nov 12, 2026